Technical
Channels

Drug Discovery

Drug Development

Drug Manufacturing

Drug Delivery

Clinical Trials

Regulatory and Legal

Alliances and Mergers

QA/QC and Compliance

Pharmaceutical Processing and Packaging

Change text size [+] [-]

Understanding Asthma for New Treatment Potential

Monday, June 29, 2009
 Email This |  Printer Friendly

Scientists from King's College London and Imperial College London believe that they have discovered a key element in the development of chronic asthma. Their research explains why the structure and function of asthmatic airways are changed or ''remodelled'' and how this contributes to chronic asthma.

Remodelling occurs when the small airways in the lungs of people change gradually with time as their lungs respond to the presence of particles such as dust, pollen and mould in the air they breathe. These changes can also be compounded by viruses and bacteria.

Airway remodelling is apparent even in the lungs of young children with asthma, and can make the condition almost impossible to control. An important aspect of airway remodelling is changes to the muscle cells which line airways. In people with asthma, these cells tend to multiply and become larger, increasing their ability to squeeze the airways and cause breathing difficulties. There is no known way of reversing airway remodelling once it has occurred.


Share this:   Del.icio.us | 
Ask the Expert

What technologies and/or practices can Asian pharma manufacturers adopt today, to ensure quality in their products?

Digital Edition



Singapore's Preclinical R&D industry should differentiate itself in Asia by competing on quality rather than on price.
Yes
No
View results


ABOUT PHARMA ASIA | FREE SUBSCRIPTION | CONTACT US

© 2010 Ten Alps Communications Asia. All rights reserved.
Use of this Web site is subjected to its Terms and Conditions of Use. View our Privacy Policy